http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0492747-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 1991-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1992-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0492747-A3 |
| titleOfInvention | Pharmaceutical preparation for topical application |
| abstract | Pharmaceutical preparations containing 1 to 10 % by weight nL-lysine salt of the 2-[(3-chloro-2-methylphenyl)amino]-3-pyridine ncarboxylic acid as active substance, 2 to 15 % by nweight pharmaceutically acceptable emulsifiers, 2 to 20 % nby weight pharmaceutically acceptable emollients, 0.01 to n0.2 % by weight pharmaceutically acceptable preservation nsubstances and the remainder water made up to 100 % by nweight, and possibly 0.2 to 5 % by weight rubefacients, the nwater being correspondingly adjusted to a total of 100 % by nweight, are suitable for topical application to nrelieve/alleviate pain and/or inflammation in humans and nanimals. |
| priorityDate | 1990-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.